Ciprofloxacin
Product Images NDC 0615-8546

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 0615-8546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ciprofloxacin Tabs 8546 1)

Chemical structure diagram of the active ingredient ciprofloxacin hydrochloride monohydrate, showing its molecular arrangement including fluorine, carboxyl, and piperazine groups.*

FDA Label Image

Chemical Structure (Ciprofloxacin Tabs 8546 2)

Chemical structure diagram of the active ingredient Ciprofloxacin, showing its molecular composition and arrangement of atoms including a fluorine atom, carboxyl group, and cyclopropyl group.*

FDA Label Image

Principal Display Panel (Ciprofloxacin Tabs 8546 3)

Ciprofloxacin Tablets USP 500 mg label with package quantity of 20 tablets. The label includes barcodes, lot number, and expiration date fields. Manufactured by Aurobindo and packaged by Vangard Labs in Glasgow, KY. The label states 'Rx only' and storage instructions for controlled room temperature. It is marked for institutional use only, with multiple smaller labels containing similar information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.